Intervention Protocol

Nicotine receptor partial agonists for alcohol dependence

  1. Natalie Walker1,*,
  2. Jonathan A Williman1,
  3. Jane Sheridan2,
  4. David Newcombe3,
  5. Hayden McRobbie4,
  6. Susanna Galea5

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 7 DEC 2011

DOI: 10.1002/14651858.CD009489

How to Cite

Walker N, Williman JA, Sheridan J, Newcombe D, McRobbie H, Galea S. Nicotine receptor partial agonists for alcohol dependence (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD009489. DOI: 10.1002/14651858.CD009489.

Author Information

  1. 1

    University of Auckland, Clinical Trials Research Unit, Auckland, New Zealand

  2. 2

    University of Auckland, Pharmacy, Auckland, New Zealand

  3. 3

    University of Auckland, School of Population Health, Auckland, New Zealand

  4. 4

    Barts & The London School of Medicine and Dentistry, Queen, UK Centre for Tobacco Control Studies, Wolfson Institute of Preventive Medicine, London, UK

  5. 5

    Sussex Partnership Trust, Department of Psychiatry, Rehabilitation and Assertive outreach, Chichester, West Sussex, UK

*Natalie Walker, Clinical Trials Research Unit, University of Auckland, Private Bag 92019, Auckland, New Zealand.

Publication History

  1. Publication Status: New
  2. Published Online: 7 DEC 2011




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of this review is to assess the efficacy and safety of nAChR partial agonists for reducing alcohol consumption in people with alcohol use disorders when compared to placebo, no intervention, psychosocial interventions or other pharmacotherapy.